$RLAY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Relay Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Relay Therapeutics, Inc.. Get notifications about new insider transactions in Relay Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | RLAY | Relay Therapeutics ... | Bergstrom Donald A | See Remarks | Option Exercise | M | 4.12 | 42,242 | 174,037 | 253,456 | |
| Jun 17 2021 | RLAY | Relay Therapeutics ... | Bergstrom Donald A | See Remarks | Sell | S | 33.75 | 42,242 | 1,425,668 | 77,241 | 119.5 K to 77.2 K (-35.35 %) |
| Jun 17 2021 | RLAY | Relay Therapeutics ... | Bergstrom Donald A | See Remarks | Buy | M | 4.12 | 42,242 | 174,037 | 119,483 | 77.2 K to 119.5 K (+54.69 %) |
| May 21 2021 | RLAY | Relay Therapeutics ... | Murcko Mark | Director | Option Exercise | A | 30.09 | 16,000 | 481,440 | 16,000 | |
| Apr 28 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Option Exercise | M | 4.12 | 6,500 | 26,780 | 160,286 | |
| Apr 28 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Option Exercise | M | 4.12 | 6,500 | 26,780 | 160,286 | |
| Apr 28 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Sell | S | 35.00 | 6,500 | 227,500 | 25,870 | 32.4 K to 25.9 K (-20.08 %) |
| Apr 28 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Sell | S | 35.00 | 6,500 | 227,500 | 25,870 | 32.4 K to 25.9 K (-20.08 %) |
| Apr 28 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Buy | M | 4.12 | 6,500 | 26,780 | 32,370 | 25.9 K to 32.4 K (+25.13 %) |
| Apr 28 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Buy | M | 4.12 | 6,500 | 26,780 | 32,370 | 25.9 K to 32.4 K (+25.13 %) |
| Apr 20 2021 | RLAY | Relay Therapeutics ... | Bergstrom Donald A | See Remarks | Sell | S | 32.36 | 56,324 | 1,822,645 | 77,241 | 133.6 K to 77.2 K (-42.17 %) |
| Apr 01 2021 | RLAY | Relay Therapeutics ... | Catinazzo Thomas | Senior Vice Preside ... | Option Exercise | M | 4.12 | 22,500 | 92,700 | 107,043 | |
| Apr 01 2021 | RLAY | Relay Therapeutics ... | Catinazzo Thomas | Senior Vice Preside ... | Sell | S | 35.00 | 22,500 | 787,500 | 0 | 22.5 K to 0 (-100.00 %) |
| Apr 01 2021 | RLAY | Relay Therapeutics ... | Catinazzo Thomas | Senior Vice Preside ... | Buy | M | 4.12 | 22,500 | 92,700 | 22,500 | 0 to 22.5 K |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Bergstrom Donald A | See Remarks | Option Exercise | A | 34.25 | 69,998 | 2,397,432 | 69,998 | |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Bergstrom Donald A | See Remarks | Grant | A | 0.00 | 34,999 | 0 | 133,565 | 98.6 K to 133.6 K (+35.51 %) |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Patel Sanjiv | President and CEO | Option Exercise | A | 34.25 | 325,000 | 11,131,250 | 325,000 | |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Patel Sanjiv | President and CEO | Gift | G | 0.00 | 150,000 | 0 | 674,548 | 524.5 K to 674.5 K (+28.60 %) |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Patel Sanjiv | President and CEO | Gift | G | 0.00 | 150,000 | 0 | 253,082 | 403.1 K to 253.1 K (-37.21 %) |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Catinazzo Thomas | Senior Vice Preside ... | Option Exercise | A | 34.25 | 31,740 | 1,087,095 | 31,740 | |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Catinazzo Thomas | Senior Vice Preside ... | Grant | A | 0.00 | 15,870 | 0 | 15,870 | 0 to 15.9 K |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Option Exercise | A | 34.25 | 31,740 | 1,087,095 | 31,740 | |
| Mar 26 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Grant | A | 0.00 | 15,870 | 0 | 25,870 | 10 K to 25.9 K (+158.70 %) |
| Mar 16 2021 | RLAY | Relay Therapeutics ... | Borisy Alexis | Director | Buy | J | 0.00 | 28,538 | 0 | 234,175 | 205.6 K to 234.2 K (+13.88 %) |
| Feb 19 2021 | RLAY | Relay Therapeutics ... | Borisy Alexis | Director | Buy | J | 0.00 | 30,194 | 0 | 205,637 | 175.4 K to 205.6 K (+17.21 %) |
| Feb 09 2021 | RLAY | Relay Therapeutics ... | Borisy Alexis | Director | Buy | J | 0.00 | 70,956 | 0 | 175,443 | 104.5 K to 175.4 K (+67.91 %) |
| Jan 29 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Option Exercise | M | 4.12 | 5,000 | 20,600 | 166,786 | |
| Jan 29 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Option Exercise | M | 4.12 | 5,000 | 20,600 | 166,786 | |
| Jan 29 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Sell | S | 55.05 | 5,000 | 275,250 | 10,000 | 15 K to 10 K (-33.33 %) |
| Jan 29 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Sell | S | 55.05 | 5,000 | 275,250 | 10,000 | 15 K to 10 K (-33.33 %) |
| Jan 29 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Buy | M | 4.12 | 5,000 | 20,600 | 15,000 | 10 K to 15 K (+50.00 %) |
| Jan 29 2021 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Buy | M | 4.12 | 5,000 | 20,600 | 15,000 | 10 K to 15 K (+50.00 %) |
| Dec 15 2020 | RLAY | Relay Therapeutics ... | Catinazzo Thomas | Senior Vice Preside ... | Option Exercise | A | 5.22 | 63,363 | 330,755 | 63,363 | |
| Dec 15 2020 | RLAY | Relay Therapeutics ... | Bergstrom Donald A | See Remarks | Option Exercise | A | 5.22 | 126,727 | 661,515 | 126,727 | |
| Dec 15 2020 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Option Exercise | A | 5.22 | 67,588 | 352,809 | 67,588 | |
| Dec 15 2020 | RLAY | Relay Therapeutics ... | Patel Sanjiv | President and CEO | Option Exercise | A | 5.22 | 753,804 | 3,934,857 | 753,804 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 61,881 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 61,881 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,920,455 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 35,404,286 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 17,427 | 0 | 2,811,197 | 2.8 M to 2.8 M (+0.62 %) |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 17,427 | 0 | 9,987,881 | 10 M to 10 M (+0.17 %) |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 2,793,770 | 0 | 2,793,770 | 0 to 2.8 M |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 9,970,454 | 0 | 9,970,454 | 0 to 10 M |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | SVF Pauling (Cayman) Ltd | 10% Owner | Option Exercise | C | 0.00 | 99,088,292 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | SVF Pauling (Cayman) Ltd | 10% Owner | Buy | C | 0.00 | 27,904,963 | 0 | 27,904,963 | 0 to 27.9 M |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Patel Sanjiv | President and CEO | Buy | P | 20.00 | 25,000 | 500,000 | 403,082 | 378.1 K to 403.1 K (+6.61 %) |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Murcko Mark | Director | Option Exercise | C | 0.00 | 990,099 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Murcko Mark | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Murcko Mark | Director | Buy | P | 20.00 | 25,000 | 500,000 | 1,021,952 | 997 K to 1 M (+2.51 %) |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Murcko Mark | Director | Buy | C | 0.00 | 278,829 | 0 | 996,952 | 718.1 K to 997 K (+38.83 %) |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Murcko Mark | Director | Buy | C | 0.00 | 281,617 | 0 | 718,123 | 436.5 K to 718.1 K (+64.52 %) |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Rubin Jami | Director | Buy | P | 20.00 | 25,000 | 500,000 | 25,000 | 0 to 25 K |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | INGRAM DOUGLAS S | Director | Buy | P | 20.00 | 25,000 | 500,000 | 25,000 | 0 to 25 K |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Adams Brian | General Counsel | Buy | P | 20.00 | 10,000 | 200,000 | 10,000 | 0 to 10 K |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Borisy Alexis | Director | Option Exercise | C | 0.00 | 371,027 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Borisy Alexis | Director | Buy | C | 0.00 | 104,487 | 0 | 104,487 | 0 to 104.5 K |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Picularium, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,651,471 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Picularium, LLC | 10% Owner | Option Exercise | C | 0.00 | 9,999,999 | 0 | 0 | |
| Jul 21 2020 | RLAY | Relay Therapeutics ... | Picularium, LLC | 10% Owner | Buy | C | 0.00 | 3,281,253 | 0 | 3,281,253 | 0 to 3.3 M |
| Jul 20 2020 | RLAY | Relay Therapeutics ... | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 1,651,471 | 0 | 0 | |
| Jul 20 2020 | RLAY | Relay Therapeutics ... | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 1,287,128 | 0 | 0 | |
| Jul 20 2020 | RLAY | Relay Therapeutics ... | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
| Jul 20 2020 | RLAY | Relay Therapeutics ... | Alexandria Venture Investments ... | 10% Owner | Buy | C | 0.00 | 968,365 | 0 | 968,365 | 0 to 968.4 K |
Page: 1